OPTIMIZATION OF ALEMTUZUMAB DOSE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR REDUCED INTENSITY TRANSPLANTATION FROM UNRELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES

被引：2
|
作者：
Gupta, V [1 ]
Xu, W. [1 ]
Sutherland, R. [2 ]
Kamel-Reid, S. [2 ]
Kuruvilla, J. [1 ]
Loach, D. [1 ]
Lipton, J. H. [1 ]
Messner, H. A. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Hlth Network, Toronto, ON, Canada
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
348
引用
收藏
页码：124 / 125
页数：2
相关论文
共 50 条
  • [1] Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in pediatric patients with hematologic malignancies transplanted from haploidentical and matched unrelated donors
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Skvortsova, J.
    Muzalevsky, I.
    Kazachenok, A.
    Ilushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Blagov, S.
    Gutovskaya, E.
    Myakova, N.
    Litvinov, D.
    Novichkova, G.
    Maschan, A.
    Maschan, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S460 - S460
  • [2] POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN PEDIATRIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES TRANSPLANTED FROM HAPLOIDENTICAL AND MATCHED UNRELATED DONORS
    Abrosimov, A.
    Shelikhova, L.
    Shekhovtsova, Z.
    Balashov, D.
    Skvortsova, Y.
    Kurnikova, E.
    Ilushina, M.
    Shipitsina, I.
    Shasheleva, D.
    Khismatullina, R.
    Gutovskaya, E.
    Blagov, S.
    Myakova, N.
    Litvinov, D.
    Baidildina, D.
    Novichkova, G.
    Maschan, M.
    Maschan, A.
    HAEMATOLOGICA, 2016, 101 : 636 - 636
  • [3] Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies
    Mori, T.
    Aisa, Y.
    Nakazato, T.
    Yamazaki, R.
    Shimizu, T.
    Mihara, A.
    Yamane, A.
    Ikeda, Y.
    Okamoto, S.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (05) : 1615 - 1619
  • [4] Reduced-intensity conditioning allogeneic transplantation from unrelated donors:: Evaluation of mycophenolate mofetil plus cyclosporin a as graft-versus-host disease prophylaxis
    Perez-Simon, Jose A.
    Martino, Rodrigo
    Caballero, Dolores
    Valcarcel, David
    Rebollo, Noemi
    de la Camara, Rafael
    Perez de Oteiza, Javier
    Heras, Inmaculada
    Calvo, Maria V.
    Sierra, Jordi
    San Miguel, Jesus F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 664 - 671
  • [5] Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies
    Passweg, Jakob R.
    Zhang, Mei-Jie
    Rocha, Vanderson
    Kan, Fangyu
    Champlin, Richard E.
    Isola, Luis M.
    Gee, Adrian P.
    Gibson, John
    Laughlin, Mary J.
    Lazarus, Hillard M.
    Loren, Alison
    Marks, David.
    Gratwohl, Alois
    Eapen, Mary
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (12) : 1869 - 1873
  • [6] Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced Hematologic diseases
    Miyakoshi, Shigesaburo
    Kami, Masahiro
    Tanimoto, Tetsuya
    Yamaguchi, Takuhiro
    Narimatsu, Hiroto
    Kusumi, Eiji
    Matsumura, Tomoko
    Takagi, Shinsuke
    Kato, Dalsuke
    Kishi, Yukiko
    Murashige, Naoko
    Yuji, Koichiro
    Uchida, Naoyuki
    Masuoka, Kazuhiro
    Wake, Atsushi
    Taniguchi, Shuichi
    TRANSPLANTATION, 2007, 84 (03) : 316 - 322
  • [7] Tacrolimus as prophylaxis for acute graft-versus-host disease in reduced intensity cord blood transplantation for adult patients with advanced hematologic diseases
    Miyakoshi, S
    Masuoka, K
    Kato, D
    Takagi, S
    Kawano, T
    Matumura, T
    Matuhshi, Y
    Uchida, N
    Wake, A
    Taniguchi, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 37 - 37
  • [8] Use of alemtuzumab as graft-versus-host disease prophylaxis in myeloablative unrelated donor transplants
    Young, K. L.
    Howard, D.
    Lekakis, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Alemtuzumab-Cyclosporine Versus Tacrolimus-Methotrexate-Sirolimus for Graft-Versus-Host Disease Prophylaxis in Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors: Final Results of a Randomized Trial
    Curtis, Lauren M.
    Pavletic, Steven Z.
    Salit, Rachel B.
    Shaffer, Brian C.
    Steinberg, Seth M.
    Wilder, Jennifer S.
    Pirsl, Filip
    Blacklock-Schuver, Bazetta
    Hsu, Jennifer
    Hughes, Thomas E.
    Stroncek, David
    Adams, Sharon
    Hendricks, Jennifer
    Avila, Daniele N.
    Mann, Jennifer
    Halverson, David C.
    Friedman, Thea M.
    Korngold, Robert
    Gea-Banacloche, Juan C.
    Fowler, Daniel H.
    Confer, Dennis L.
    Hakim, Frances T.
    Gress, Ronald E.
    Bishop, Michael R.
    BLOOD, 2015, 126 (23)
  • [10] HIGH DOSE CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PEDIATRIC HEMATOLOGIC MALIGNANCIES
    Jacoby, Elad
    Chen, Allen
    Fuchs, Ephraim
    Jones, Rick
    Luznik, Leo
    Symons, Heather
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S98 - S98
12345